Rates of Suspected Endophthalmitis Following Intravitreal Injections in Clinical Practices in the United States
BACKGROUND AND OBJECTIVE: To evaluate rates of suspected endophthalmitis following intravitreal injections of aflibercept, bevacizumab, ranibizumab (vial and pre-filled), dexamethasone implant, and triamcinolone in clinical practice
Bibliographische Detailangaben
| Veröffentlicht in: | Ophthalmic surgery, lasers & imaging retina. - 2013. - 52(2021), 6 vom: 16. Juni, Seite 312-318
|
|---|
| 1. Verfasser: |
Dhoot, Dilsher S
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Boucher, Nick,
Pitcher, John D 3rd,
Saroj, Namrata |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2021
|
|---|
| Zugriff auf das übergeordnete Werk: | Ophthalmic surgery, lasers & imaging retina
|
|---|
| Schlagworte: | Journal Article
Angiogenesis Inhibitors
Vascular Endothelial Growth Factor A
Bevacizumab
2S9ZZM9Q9V
Receptors, Vascular Endothelial Growth Factor
EC 2.7.10.1
Ranibizumab
ZL1R02VT79 |
|---|